Trial Profile
A Study to Evaluate the Effect of Regadenoson on QTc Interval in Patients udergoing Pharmacological Stress Test
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Feb 2016
Price :
$35
*
At a glance
- Drugs Regadenoson (Primary)
- Indications Coronary disorders
- Focus Adverse reactions; Diagnostic use
- 25 Feb 2016 New trial record